骨质疏松对口腔种植修复影响的研究进展

doi:10.19438/j.cjoms.2023.01.014

摘要/Abstract

摘要： 骨质疏松症是一种全身性骨代谢疾病,好发于中老年人群。随着老年人口的增多,发病率也逐年上升。同时,伴随着口腔种植技术的发展和成熟,有越来越多的老年人选择进行种植修复。骨质疏松曾被认为是口腔种植修复的危险因素之一,对种植体的初期稳定性、生存率可能存在影响,且骨质疏松治疗药物不可避免地对种植体骨结合产生影响。本文就骨质疏松对口腔种植修复影响的研究进展进行综述。

关键词: 骨质疏松, 口腔种植, 初期稳定性, 骨整合, 药物相关性颌骨坏死

Abstract: Osteoporosis is a systemic bone metabolism disease that occurs in middle-aged and elderly people. The incidence of osteoporosis is increasing year by year with the increase of the elderly population. Meanwhile, with the progress of dental implant technology, more and more elderly people undergo implant restoration. Osteoporosis was once considered to be one of the risk factors for dental implant restoration, which may influence the initial stability and survival rate of implants, and drugs for osteoporosis treatment also inevitably affect the osseointegration of implants. This article reviewed relevant studies to summarize the impact of osteoporosis on dental implant restoration.

Key words: Osteoporosis, Dental implantation, Initial stability, Osseointegration, Drug-related osteonecrosis of the jaw

中图分类号:

R782.1

金夏悦, 顾迎新. 骨质疏松对口腔种植修复影响的研究进展[J]. 中国口腔颌面外科杂志, 2023, 21(1): 81-86.

JIN Xia-yue, GU Yin-xin. Research progress of the effect of osteoporosis on dental implant restoration[J]. China J Oral Maxillofac Surg, 2023, 21(1): 81-86.

参考文献

[1] NO authors listed. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis[J]. Am J Med, 1993, 94(6): 646-650.
[2] 韩亚军, 帖小佳, 伊力哈木·托合提. 中国中老年人骨质疏松症患病率的meta分析[J]. 中国组织工程研究, 2014, 18(7): 1129-1134.
Han YJ, Tie XJ, Yilihanmu·Tuoheti. Meta-analysis on the prevalence rate of osteoporosis in the middle-aged and elderly in China[J]. Chinese Journal of Tissue Engineering Research, 2014, 18(7): 1129-1134.
[3] Tsolaki IN, Madianos PN, Vrotsos JA.Outcomes of dental implants in osteoporotic patients. A literature review[J]. J Prosthodont, 2009, 18(4): 309-323.
[4] Arioka M, Zhang X, Li Z, et al.Osteoporotic changes in the periodontium impair alveolar bone healing[J]. J Dent Res, 2019, 98(4): 450-458.
[5] Calciolari E, Donos N, Park JC, et al.A systematic review on the correlation between skeletal and jawbone mineral density in osteoporotic subjects[J]. Clin Oral Implants Res, 2016, 27(4): 433-442.
[6] Hohlweg-Majert B, Schmelzeisen R, Pfeiffer BM, et al.Significance of osteoporosis in craniomaxillofacial surgery: a review of the literature[J]. Osteoporos Int, 2006, 17(2): 167-179.
[7] Dereka X, Calciolari E, Donos N, et al.Osseointegration in osteoporotic-like condition: a systematic review of preclinical studies[J]. J Periodontal Res, 2018, 53(6): 933-940.
[8] Só BB, Silveira FM, Llantada GS, et al.Effects of osteoporosis on alveolar bone repair after tooth extraction: a systematic review of preclinical studies[J]. Arch Oral Biol, 2021, 125: 105054.
[9] Chambrone L.Current status of the influence of osteoporosis on periodontology and implant dentistry[J]. Curr Opin Endocrinol Diabetes Obes, 2016, 23(6): 435-439.
[10] Féron JM, Mauprivez R.Fracture repair: general aspects and influence of osteoporosis and anti-osteoporosis treatment[J]. Injury, 2016, 47(Suppl 1): S10-S14.
[11] Merheb J, Temmerman A, Rasmusson L, et al.Influence of skeletal and local bone density on dental implant stability in patients with osteoporosis[J]. Clin Implant Dent Relat Res, 2016, 18(2): 253-260.
[12] Albrektsson T, Jacobsson M.Bone-metal interface in osseointegration[J]. J Prosthet Dent, 1987, 57(5): 597-607.
[13] Mori H, Manabe M, Kurachi Y, et al.Osseointegration of dental implants in rabbit bone with low mineral density[J]. J Oral Maxillofac Surg, 1997, 55(4): 351-361.
[14] Friberg B, Ekestubbe A, Mellström D, et al.Brönemark implants and osteoporosis: a clinical exploratory study[J]. Clin Implant Dent Relat Res, 2001, 3(1): 50-56.
[15] Pan J, Shirota T, Ohno K, et al.Effect of ovariectomy on bone remodeling adjacent to hydroxyapatite-coated implants in the tibia of mature rats[J]. J Oral Maxillofac Surg, 2000, 58(8): 877-882.
[16] Liu XL, Li CL, Lu WW, et al.Skeletal site-specific response to ovariectomy in a rat model: change in bone density and microarchitecture[J]. Clin Oral Implants Res, 2015, 26(4): 392-398.
[17] Moriya Y, Ito K, Murai S.Effects of experimental osteoporosis on alveolar bone loss in rats[J]. J Oral Sci, 1998, 40(4): 171-175.
[18] Giro G, Chambrone L, Goldstein A, et al.Impact of osteoporosis in dental implants: a systematic review[J]. World J Orthop, 2015, 6(2): 311-315.
[19] Holahan CM, Koka S, Kennel KA, et al.Effect of osteoporotic status on the survival of titanium dental implants[J]. Int J Oral Maxillofac Implants, 2008, 23(5): 905-910.
[20] Olmedo-Gaya MV, Manzano-Moreno FJ, Cañaveral-Cavero E, et al.Risk factors associated with early implant failure: a 5-year retrospective clinical study[J]. J Prosthet Dent, 2016, 115(2): 150-155.
[21] Attard NJ, Zarb GA.Long-term treatment outcomes in edentulous patients with implant overdentures: the Toronto study[J]. Int J Prosthodont, 2004, 17(4): 425-433.
[22] Balshi SF, Allen FD, Wolfinger GJ, et al.A resonance frequency analysis assessment of maxillary and mandibular immediately loaded implants[J]. Int J Oral Maxillofac Implants, 2005, 20(4): 584-594.
[23] 夏维波, 章振林, 林华, 等. 原发性骨质疏松症诊疗指南(2017)[J]. 中国骨质疏松杂志, 2019, 25(3): 281-309.
Xia WB, Zhang ZL, Lin H, et al.Guidelines for diagnosis and management of primary osteoporosis (2017)[J]. Chinese Journal of Osteoporosis, 2019, 25(3): 281-309.
[24] Cheong S, Sun S, Kang B, et al.Bisphosphonate uptake in areas of tooth extraction or periapical disease[J]. J Oral Maxillofac Surg, 2014, 72(12): 2461-2468.
[25] Vohra F, Al-Rifaiy MQ, Almas K, et al.Efficacy of systemic bisphosphonate delivery on osseointegration of implants under osteoporotic conditions: lessons from animal studies[J]. Arch Oral Biol, 2014, 59(9): 912-920.
[26] Chen B, Li Y, Yang X, et al.Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats[J]. Osteoporos Int, 2013, 24(7): 2115-2121.
[27] Wang HL, Weber D, Mccauley LK.Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report[J]. J Periodontol, 2007, 78(3): 584-594.
[28] Ameican Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations[J]. J Am Dent Assoc, 2006, 137(8): 1144-1150.
[29] Piesold JU, Al-Nawas B, Grötz KA.Osteonecrosis of the jaws by long term therapy with bisphosphonates[J]. Mund Kiefer Gesichtschir, 2006, 10(5): 287-300.
[30] Schimmel M, Srinivasan M, Mckenna G, et al.Effect of advanced age and/or systemic medical conditions on dental implant survival: a systematic review and meta-analysis[J]. Clin Oral Implants Res, 2018, 29(Suppl 16): 311-330.
[31] Lazarovici TS, Yahalom R, Taicher S, et al.Bisphosphonate-related osteonecrosis of the jaw associated with dental implants[J]. J Oral Maxillofac Surg, 2010, 68(4): 790-796.
[32] Mattheos N, Caldwell P, Petcu EB, et al.Dental implant placement with bone augmentation in a patient who received intravenous bisphosphonate treatment for osteoporosis[J]. J Can Dent Assoc, 2013, 79: d2.
[33] Hadaya D, Soundia A, Gkouveris I, et al.Antiresorptive-type and discontinuation-timing affect onj burden[J]. J Dent Res, 2021, 100(7): 746-753.
[34] Apostu D, Lucaciu O, Lucaciu GD, et al.Systemic drugs that influence titanium implant osseointegration[J]. Drug Metab Rev, 2017, 49(1): 92-104.
[35] Aspenberg P, Agholme F, Magnusson P, et al.Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening[J]. Bone, 2011, 48(2): 225-230.
[36] Chen BL, Xie DH, Zheng ZM, et al.Comparison of the effects of alendronate sodium and calcitonin on bone-prosthesis osseointegration in osteoporotic rats[J]. Osteoporos Int, 2011, 22(1): 265-270.
[37] Omar MG, El-Refai SM, Khalil E, et al.Effect of systemic calcitonin delivery with and without adjunct local platelet-rich fibrin therapy on osseointegration in ovariectomized osteoporotic rabbits: a scanning electron microscopy-based study[J]. Oral Health Prev Dent, 2021, 19(1): 365-371.
[38] Narai S, Nagahata S.Effects of alendronate on the removal torque of implants in rats with induced osteoporosis[J]. Int J Oral Maxillofac Implants, 2003, 18(2): 218-223.
[39] Qi MC, Zhou XQ, Hu J, et al.Oestrogen replacement therapy promotes bone healing around dental implants in osteoporotic rats[J]. Int J Oral Maxillofac Surg, 2004, 33(3): 279-285.
[40] August M, Chung K, Chang Y, et al.Influence of estrogen status on endosseous implant osseointegration[J]. J Oral Maxillofac Surg, 2001, 59(11): 1285-1289.
[41] 王敏娇, 司家文, 沈国芳. 促进骨形成的甲状旁腺激素:作用及机制[J]. 中国组织工程研究, 2015, 19(15): 2405-2409.
Wang MJ, Si JW, Shen GF.The role and mechanism of parathyroid hormone in promoting bone formation[J]. Journal of Clinical Rehabilitative Tissue Engineering Research, 2015, 19(15): 2405-2409.
[42] Yang X, Ricciardi BF, Dvorzhinskiy A, et al.Intermittent parathyroid hormone enhances cancellous osseointegration of a novel murine tibial implant[J]. J Bone Joint Surg Am, 2015, 97(13): 1074-1083.
[43] Daugaard H, Elmengaard B, Andreassen T, et al.Parathyroid hormone treatment increases fixation of orthopedic implants with gap healing: a biomechanical and histomorphometric canine study of porous coated titanium alloy implants in cancellous bone[J]. Calcif Tissue Int, 2011, 88(4): 294-303.
[44] Gao X, Meng Y, Hao D, et al.Parathyroid hormone enhances gap healing and osseointegration in orthopedic porous coated titanium implants: a correlative micro-computed tomographic, histomorphometric and biomechanical analysis[J]. BMC Musculoskelet Disord, 2022, 23(1): 17.
[45] Javed F, Al Amri MD, Kellesarian SV, et al.Efficacy of parathyroid hormone supplementation on the osseointegration of implants: a systematic review[J]. Clin Oral Investig, 2016, 20(4): 649-658.
[46] Fonseca JE, Brandi ML.Mechanism of action of strontium ranelate: what are the facts?[J]. Clin Cases Miner Bone Metab, 2010, 7(1): 17-18.
[47] Li Y, Li X, Song G, et al.Effects of strontium ranelate on osseointegration of titanium implant in osteoporotic rats[J]. Clin Oral Implants Res, 2012, 23(9): 1038-1044.
[48] Linderbäck P, Agholme F, Wermelin K, et al.Weak effect of strontium on early implant fixation in rat tibia[J]. Bone, 2012, 50(1): 350-356.
[49] Satué M, Petzold C, Córdoba A, et al.UV photoactivation of 7-dehydrocholesterol on titanium implants enhances osteoblast differentiation and decreases rankl gene expression[J]. Acta Biomater, 2013, 9(3): 5759-5770.
[50] Zhou CC, Li YF, Wang XM, et al.1,25 dihydroxy vitamin D₃ improves titanium implant osseointegration in osteoporotic rats[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2012, 114(5 suppl): S174-S178.
[51] Javed F, Malmstrom H, Kellesarian SV, et al.Efficacy of vitamin D₃ supplementation on osseointegration of implants[J]. Implant Dent, 2016, 25(2): 281-287.
[52] Hasani-Sadrabadi MM, Pouraghaei S, Zahedi E, et al.Antibacterial and osteoinductive implant surface using layer-by-layer assembly[J]. J Dent Res, 2021, 100(10): 1161-1168.
[53] Tresguerres IF, Clemente C, Donado M, et al.Local administration of growth hormone enhances periimplant bone reaction in an osteoporotic rabbit model[J]. Clin Oral Implants Res, 2002, 13(6): 631-636.
[54] Lo JC, O'ryan FS, Gordon NP, et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure[J]. J Oral Maxillofac Surg, 2010, 68(2): 243-253.
[55] Ruggiero SL, Dodson TB, Fantasia J, et al.American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update[J]. J Oral Maxillofac Surg, 2014, 72(10): 1938-1956.
[56] Hellstein JW, Adler RA, Edwards B, et al.Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American dental association council on scientific affairs[J]. J Am Dent Assoc, 2011, 142(11): 1243-1251.